2 The reported 30-day complication rate is 3.7% and hospital admissions attributed to TRUS is between 0.8% and 6.9% with the majority of complication being due to infections. ![]() 1 It is the preferred method used to biopsy the prostate by most urologist in the world, as well as in the United States. Transrectal ultrasound-guided (TRUS) biopsy has been the gold standard for prostate biopsy for the last 2 decades. 1 P = .006) that were treated with antibiotics on outside basis. However, more patients had urinary tract infection in the transrectal ultrasound-guided biopsy group compared to transperineal biopsy group (5 vs. No difference in hematuria, retention, and sepsis rate requiring admission (1 vs. 0001), and the detection rate of clinically significant cancer was similar between the groups (44% vs. 13 P = .025) fewer average number of random cores (3 vs. Those that underwent transperineal biopsy had fewer average total number of cores compared to transrectal ultrasound-guided biopsy (11 vs. ![]() 7.5 P = .42), and median prostate volume (51 vs. 66 years P = .68), median prostate-specific antigen value (7.5 vs. ![]() Patients had similar prebiopsy parameters (transperineal vs. In all, 98 transperineal biopsies and 47 transrectal magnetic resonance imaging/ultrasound fusion prostate biopsies were done.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |